Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Feb 27;14(1):49-51.
doi: 10.4103/ojo.OJO_103_2020. eCollection 2021 Jan-Apr.

Full-thickness macular hole formation following antivascular endothelial growth factor injection in a case of hemicentral retinal vein occlusion

Srijita Mitra  1 , Sahil Sarpal  1 , Abhijit Chattopadhyay  2 , Subhankarsri Paul  2 , Jonaki Ghosh Roy  2
Affiliations
Case Reports

Full-thickness macular hole formation following antivascular endothelial growth factor injection in a case of hemicentral retinal vein occlusion

Srijita Mitra et al. Oman J Ophthalmol. .

Abstract

A rare case reporting the occurrence of full-thickness macular hole (MH) formation following intravitreal antivascular endothelial growth factor injection in a case of hemicentral retinal vein occlusion and the subsequent management of the case. As described in few other similar case reports in the literature, there are quite a few probabilities of factors causing this pathology. An acute posterior vitreous detachment or sudden decompression of the macular edema can quite possibly lead to the above situation. This case report shares light on the evolution of a MH following intravitreal injection and the subsequent treatment process.

Keywords: Bevacizumab; cystoid macular edema; intravitreal injections; macular hole; retinal vein occlusion.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
(a) Clinical picture at presentation (b) corresponding optical coherence tomography
Figure 2
Figure 2
(a) Full-thickness macular hole following injection (b) full-thickness macular hole-corresponding optical coherence tomography
Figure 3
Figure 3
(a) Following vitrectomy (b) Optical coherence tomography following vitrectomy- Type 1 closure
Figure 4
Figure 4
Clinical picture – last visit
See this image and copyright information in PMC

References

    1. Muramatsu D, Mitsuhashi R, Iwasaki T, Goto H, Miura M. Macular hole formation following intravitreal injection of ranibizumab for branch retinal vein occlusion: A case report. BMC Res Notes. 2015;8:358. - PMC - PubMed
    1. Forooghian F, Kertes PJ, Eng KT, Agrón E, Chew EY. Alterations in the intraocular cytokine milieu after intravitreal bevacizumab. Invest Ophthalmol Vis Sci. 2010;51:2388–92. - PMC - PubMed
    1. Querques G, Souied EH, Soubrane G. Macular hole following intravitreal ranibizumab injection for choroidal neovascular membrane caused by age-related macular degeneration. Acta Ophthalmol. 2009;87:235–7. - PubMed
    1. Lecleire-Collet A, Offret O, Gaucher D, Audren F, Haouchine B, Massin P. Full-thickness macular hole in a patient with diabetic cystoid macular oedema treated by intravitreal triamcinolone injections. Acta Ophthalmol Scand. 2007;85:795–8. - PubMed
    1. Miura M, Iwasaki T, Goto H. Macular hole formation after intravitreal bevacizumab administration in a patient with myopic choroidal neovascularization. Retin Cases Brief Rep. 2011;5:149–52. - PubMed

Publication types